Breaking News

GlycoMimetics Receives $15M Pfizer Milestone

May 21, 2014

Rivipansel moves to Phase III development

GlycoMimetics, Inc. has received a $15 million payment from Pfizer under the companies’ collaboration for the development of rivipansel (GMI-1070). Pfizer plans to initiate a Phase III trial of rivipansel, which will trigger an additional $20 million milestone payment to GlycoMimetics upon dosing of the first patient in the trial.
 
“Moving into Phase III will be a significant step forward in our effort to potentially address the unmet needs of individuals with sickle cell disease. With the commitment of our collaborator, Pfizer, we hope this will enable us to bring to patients, caregivers and physicians an important new medication for treatment of vaso-occlusive crisis or VOC of sickle cell disease,” said Rachel King, chief executive officer, GlycoMimetics.
 
The companies entered the collaboration and exclusive license agreement with for rivipansel in October 2011. The companies are currently developing rivipansel as a potential treatment for VOC of sickle cell disease.

blog comments powered by Disqus
  • Cold Chain Packaging Trends

    Cold Chain Packaging Trends

    Kristin Brooks, Contract Pharma||February 4, 2016
    Susan Li of UPS discusses supply chain trends, challenges, and packaging innovations

  • Packaging Equipment Trends Preview

    Packaging Equipment Trends Preview

    Kristin Brooks, Contract Pharma||January 26, 2016
    Christian Treitel of Bosch Packaging Technology discusses trends and capabilities

  • Filings Update

    Filings Update

    December 1, 2015
    Roche, Pfizer, Janssen, BMS and more

  • CMC Biologics: Growing Through Innovation

    Tim Wright, Editor||January 28, 2016
    The new chief exec talks about industry trends and growth plans.

  • Cold-Chain Logistics & The Central Lab

    Kristin Brooks, Associate Editor||January 28, 2016
    Eric Hayashi of LabConnect discusses safety measures to ensure sample integrity

  • A Look at DCAT Week ‘16

    Tim Wright, Editor||January 28, 2016
    On the pulse of the pharmaceutical manufacturing value chain, DCAT Week ‘16 will deliver top-flight education programs and networking events.